Neutrophilic Asthma
Conditions
Keywords
severe asthma, induced sputum, asthma phenotypes, neutrophilic inflammation, microbiome
Brief summary
Define and characterize the neutrophilic phenotype of severe asthma.
Detailed description
Neutrophilic asthma (NA) is the asthma phenotype less known, causes a severe disease and does not have a specific treatment. Research on the neutrophilia mechanisms, new neutrophil (NEU) types and bronchial microbiome, can provide an opportunity to better understand the NA pathogenesis. OBJECTIVES: 1. To describe the clinical characteristics of NA and its sub-phenotypes (SUBSTUDY 1); 2. To determine the NEU types associated with the NA and its sub-phenotypes (SUBSTUDY 2); and 3. To identify the bronchial microbiological flora of the NA, specifically related to lung microbiome and the immune response against Chlamydia Pneumoniae (SUBSTUDY 3). METHODS: Multicenter prospective study including 100 patients with severe asthma (GINA/GEMA criteria): 50 with non-neutrophilic asthma (\<65% NEU in induced sputum \[IS\]); and 50 with NA (\> 64% NEU in IS). SUBSTUDY 1: clinical variables (years of evolution, exacerbations, asthma control test, mini asthma quality of life questionnary), comorbidities (GERD, nasal polyposis, obesity, ASS), pulmonary function (FEV1, exhaled fraction of nitric oxide, total lung capacity, Aspergillus), prick-test and CT scan chest; SUBSTUDY 2 (in IS and plasma): apoptotic index by means NE culture and flux cytometer (Annexin-V-FITC), NEU phenotype by surface markers (CD16, CD66b, CD62L, HLADR, CD177, CD11b, CD63, CXCR2, CXCR4) with density gradient study and determination of cytokines (IL-6, IL-8, IL-17, IL-1, IL-22) by ELISA; SUBSTUDY 3 (in IS): bronchial microbiome for 16 subunit rRNA by Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt), and anti-Chlamydia Pneumoniae Immunoglobuling A by ELISA.
Interventions
DIAGNOSTIC_TESTInduced sputum
Characterization with flow cytometry of the phenotype of the neutrophils isolated in the sputum, microbiome
Sponsors
Spanish Clinical Research Network - SCReN
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* 18 - 80 years old * Confirmed diagnosis of asthma (according to spanish guideline GEMA) * Severe persistent asthma (step 5-6 GEMA) * Eosinophils\<300/mm3 in peripheral blood
Exclusion criteria
* Respiratory infection during the previous month * Significant lung pathology not attributable to asthma (bronchiectasis with Reiff score\>3)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Phenotype of neutrophils | 24 hours | To determine the types of neutrophils (in induced sputum and blood) associated with neutrophilic asthma and its subphenotypes according to flow cytometry |
| Microbiome analysis | 6 months | To analyse the bronchial microbiological flora of neutrophilic asthma |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Clinical demographic characteristics | 1 year | To describe the clinical characteristics and natural history of the neutrophilic asthma and its subphenotypes |
| Demographic characteristics | 1 year | To describe demographic characteristics |
Countries
Spain
Outcome results
None listed